Beijing Bohui Innovation Biotechnology Group Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 751.6 million compared to CNY 682.18 million a year ago. Revenue was CNY 795.93 million compared to CNY 714.75 million a year ago.

Net loss was CNY 78.33 million compared to CNY 322.18 million a year ago. Basic loss per share from continuing operations was CNY 0.0959 compared to CNY 0.3944 a year ago. Diluted loss per share from continuing operations was CNY 0.0959 compared to CNY 0.3944 a year ago.